Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 28 August

Jessica Amir
August 28, 2020

Morning Bell 27 August

Jessica Amir
August 27, 2020

Morning Bell 26 August

Bell Direct
August 26, 2020

Morning Bell 25 August

Jessica Amir
August 25, 2020

Morning Bell 24 August

Jessica Amir
August 24, 2020

Weekly Wrap 21 August

Jessica Amir
August 21, 2020

Morning Bell 21 August

Jessica Amir
August 21, 2020

Morning Bell 20 August

Jessica Amir
August 20, 2020